Optimized Heart Failure Therapy and Complete Anemia Correction on Left-Ventricular Hypertrophy in Nondiabetic and Diabetic Patients Undergoing Hemodialysis

Publisher： Karger

E-ISSN： 1423-0143|28|5-6|353-362

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.28, Iss.5-6, 2006-03, pp. : 353-362

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Optimized Heart Failure Therapy and Anemia Correction with Epoetin β on Left Ventricular Mass in Hemodialysis Patients

By  

American Journal of Nephrology, Vol. 25, Iss. 3, 2005-07 ,pp. : 211-220

Karger

Access to resources Recommend Favorite

Hypoalbuminemia as a Risk Factor for Progressive Left-Ventricular Hypertrophy in Hemodialysis Patients

By  

American Journal of Nephrology, Vol. 20, Iss. 5, 2000-11 ,pp. : 396-401

Karger

Access to resources Recommend Favorite

Coronary Artery Diameter and Left Ventricular Function in Patients on Maintenance Hemodialysis Treatment: Comparison between Diabetic and Nondiabetic Patients

By  

Nephron, Vol. 80, Iss. 3, 1998-11 ,pp. : 269-273

Karger

Access to resources Recommend Favorite

No Association between Deletion-Type Angiotensin-Converting Enzyme Gene Polymorphism and Left-Ventricular Hypertrophy in Hemodialysis Patients

By  

Nephron, Vol. 84, Iss. 2, 2000-01 ,pp. : 130-135

Karger

Access to resources Recommend Favorite

Left Ventricular Hypertrophy in Incident Dialysis Patients Randomized to Treatment with Hemofiltration or Hemodialysis: Results from the ProFil Study

By  

Blood Purification, Vol. 32, Iss. 1, 2011-01 ,pp. : 21-29

Karger

Access to resources Recommend Favorite